UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034705
Receipt number R000039570
Scientific Title An observational study for comparison of diagnostic yield, maneuverability and safety between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.
Date of disclosure of the study information 2018/11/01
Last modified on 2023/11/06 10:39:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An observational study for comparison of diagnostic yield, maneuverability and safety between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.

Acronym

An observational study for comparison of diagnostic yield, maneuverability and safety between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.

Scientific Title

An observational study for comparison of diagnostic yield, maneuverability and safety between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.

Scientific Title:Acronym

An observational study for comparison of diagnostic yield, maneuverability and safety between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.

Region

Japan


Condition

Condition

malignant and benign mediastinal hilar lymphadenopathy.

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To comparison of diagnostic yield, maneuverability and safety between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of the diagnostic yield between 22-gauge and 25-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration.

Key secondary outcomes

Comparison of the diagnostic yield based on malignant and benign regions, histological diagnostic yield and cytological diagnostic yield, quantity of histological core tissue, maneuverability, safety


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with hilar and mediastinal lymphadenopathy.
20 years old and above

Key exclusion criteria

Patients who are considered as inappropriate by physician.
Rebiopsy to detect resistance mutation

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Tadashi
Middle name
Last name Sakaguchi

Organization

Matsusaka Municipal Hospital

Division name

Department of respiratory medicine

Zip code

515-8544

Address

1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan

TEL

0598-23-1515

Email

mchsakaguchi@city-hosp.matsusaka.mie.jp


Public contact

Name of contact person

1st name Tadashi
Middle name
Last name Sakaguchi

Organization

Matsusaka Municipal Hospital

Division name

Department of respiratory medicine

Zip code

515-8544

Address

1550, Tonomachi, Matsusaka, Mie, 515-0073, Japan

TEL

0598-23-1515

Homepage URL


Email

mchsakaguchi@city-hosp.matsusaka.mie.jp


Sponsor or person

Institute

Matsusaka Municipal Hospital

Institute

Department

Personal name



Funding Source

Organization

Matsusaka Municipal Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Matsusaka municipal hospital

Address

1550, Tonomachi, Matsusaka, Mie,

Tel

0598-23-1515

Email

mch1031@city-hosp.matsusaka.mie.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

60

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2018 Year 10 Month 25 Day

Date of IRB

2018 Year 10 Month 25 Day

Anticipated trial start date

2018 Year 11 Month 01 Day

Last follow-up date

2023 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

preparing the results of the study


Management information

Registered date

2018 Year 10 Month 30 Day

Last modified on

2023 Year 11 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039570


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name